SCHRODINGER
SCHRODINGER logo

Schrödinger is a leading provider of software solutions for drug discovery and development. The company's platform combines artificial intelligence, machine learning, and high-performance computing to help pharmaceutical companies find new drugs more quickly and efficiently. The platform includes a variety of tools and services, such as: * Molecular modeling: This tool allows scientists to visualize and simulate the structure and properties of molecules. * Drug design: This tool helps scientists design new drugs that are more likely to be effective and safe. * Virtual screening: This tool allows scientists to screen large libraries of molecules to find those that are most likely to bind to a target protein. * In vitro experiments: This tool allows scientists to test the effects of drugs in cells and animals. Schrödinger's platform has been used to discover and develop a number of new drugs, including: * Ibrutinib, a drug for treating chronic lymphocytic leukemia. * Venetoclax, a drug for treating chronic myeloid leukemia. * Olaparib, a drug for treating ovarian cancer.

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.

© 2023-24 DxMultiomics. All rights reserved.